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Abstract
Major depression occurs at high prevalence in the general population, often starts in juvenile years, recurs over a lifetime,
and is strongly associated with disability and suicide. Searches for biological markers in depression may have been hindered
by assuming that depression is a unitary and relatively homogeneous disorder, mainly of mood, rather than addressing
particular, clinically crucial features or diagnostic subtypes. Many studies have implicated quantitative alterations of motility
rhythms in depressed human subjects. Since a candidate feature of great public-health significance is the unusually high risk
of suicidal behavior in depressive disorders, we studied correlations between a measure (vulnerability index [VI]) derived
from multi-scale characteristics of daily-motility rhythms in depressed subjects (n= 36) monitored with noninvasive, wrist-
worn, electronic actigraphs and their self-assessed level of suicidal thinking operationalized as a wish to die. Patient-subjects
had a stable clinical diagnosis of bipolar-I, bipolar-II, or unipolar major depression (n= 12 of each type). VI was associated
inversely with suicidal thinking (r= –0.61 with all subjects and r= –0.73 with bipolar disorder subjects; both p,0.0001) and
distinguished patients with bipolar versus unipolar major depression with a sensitivity of 91.7% and a specificity of 79.2%. VI
may be a useful biomarker of characteristic features of major depression, contribute to differentiating bipolar and unipolar
depression, and help to detect risk of suicide. An objective biomarker of suicide-risk could be advantageous when patients
are unwilling or unable to share suicidal thinking with clinicians.
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Introduction
The scientific and diagnostic validity of proposed clinical
disorders can be supported by biological markers [1]. Such
indicators can lead to pathophysiological or etiological theories,
may foster early diagnosis, and support improved prognosis and
treatment [2]. Development of such markers is particularly urgent
for major mood disorders, which are prevalent, often start early in
life with multiple recurrences, and affect nearly 10% of the general
population in a lifetime [3]. They are leading international causes
of disability and carry risk of premature mortality from suicide and
other violence, as well as adverse outcomes of comorbid medical
illnesses [3,4]. These risks are particularly high in bipolar (manic-
depressive) mood disorders [5].
The search for potential biological markers of clinical de-
pression probably has been hindered by currently employed,
standardized diagnostic criteria. In particular, it is recognized that
diagnoses of major depressive disorder based on the influential
DSM-IV taxonomy are broad and limited in both specificity and
longitudinal stability [6,7]. Furthermore, excessive focus on
changes in mood as a hallmark, as well as the assumption that
clinical depression is largely homogeneous may be misleading and
probably have contributed to the lack of credible biomarkers [8].
A potentially more effective strategy is to focus on particular
aspects of clinical depression and bipolar disorders. These include
diagnostic subtypes as well as particularly striking, characteristic,
and clinically important features. Candidate targets include more
reliable and earlier differentiation of recurrent unipolar major
depression from bipolar disorder and its subtypes, I (with mania)
and II (depression with hypomania), as well as improved
prediction of suicide risk [9,10].
The search for biomarkers of suicide is particularly challenging
as vulnerability to suicidal behaviors is a highly complex
phenomenon. Suicide risk is most likely mediated by a genetic
diathesis interacting with environmental and psychosocial risk
factors as well as epigenetic mechanisms that alter the function of
neuronal circuits early in life, and exert effects persisting
throughout adulthood [11,12,13].
Relevant biological, psychosocial and environmental risk factors
for suicidal behaviors include maternal stress during pregnancy,
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restricted fetal growth, birth complications and deprivation of
normal parental care during infancy as well as precocious
adversities such as sexual and physical abuse, neglect, parental
loss and family discord. Decades of research have documented
abnormalities in the hypothalamic-pituitary-adrenal axis (HPA), as
well as the noradrenergic and serotonergic systems with altered
stress-sensitivity responses reported in individuals with suicidal
behavior as well as during major depression [11,14,15]. In
addition, early exposure to violence, substance abuse, and head
injury have proven to mold stress responses in the brain and
thereby affect the risk of suicide in major depression [11,13].
Recent studies have sought evidence of a neurobiological
contribution to suicide risk based on an endophenotype strategy
aimed at identifying quantitative measures that reflect stable,
genetically-influenced changes in brain function [16,17]. Candi-
date endophenotypes include impulsive-aggressive personality
traits, deficits in risk-assessment, and possibly related disturbances
in prefrontal cortical functioning and in neuroendocrine responses
[11,13,17].
A promising alternative to a traditional focus on changes in
mood in major depression to better identify core aspects for
defining potential biomarkers, is psychomotor activity. This
objective and quantifiable factor has been of interest for depressive
disorders for more than a century. Notably, in the 1890s, Wilhelm
Weygandt described the clinical value of structured self-training
for voluntary activation of certain groups of muscles to induce
specific changes of mood, based on methods employed by theater
actors [18]. More recently, many studies have implicated
quantitative alterations in circadian and ultradian rhythms of
psychomotor activity associated with clinical affective states
[19,20]. Motor activity can be conveniently and noninvasively
recorded for prolonged periods in human subjects with wrist-worn,
microprocessor-controlled, piezoelectric actigraphic devices that
provide objective, quantitative evaluation of motility levels as well
as their dynamic changes [21].
Actigraphy has documented reduced total activity or blunted
amplitude of daily motility rhythms in major depression [22], often
with circadian phase-advances. Such alterations have been
particularly striking among subjects diagnosed with bipolar
disorder during mania, depression or shortly before or after acute
episodes of illness, as well as in mild or subsyndromal morbid
phases [19,20,23]. Also reported are phase-delays of circadian
motility cycles in major depression, bipolar depression, and
seasonal affective disorders [24,25]. Some changes persist after
clinical recovery from depression or mania, and so may serve as
biomarkers of stable traits, and not only as covariates of current
mood-states [22,26].
Based on wavelet analysis of motility data from patients with
mood disorders, we recently reported a scaling behavior of
amplitudes of the rhythms at multiple time-scales ranging from
minutes to hours. The amplitude of these rhythms exhibited a long-
tail distribution at time-scales up to 2 hours [27]. Such a long-tail
amplitude distribution is characteristic of nonlinear complex
systems [28]. Based on application of a Gamma function to the
distribution of amplitudes (see Methods), we derived a novel
vulnerability index (VI), by integrating the shape parameters obtained
by fitting amplitude distribution to a Gamma function up to scales
of 2 hours. The VI could distinguish between: (i) currently healthy
subjects at high- versus low-risk for type-I bipolar disorder, (ii)
clinically stable or euthymic type-I bipolar disorder patients from
healthy controls, (iii) and among clinical states in type-I bipolar
disorder patients, based on higher values of the index with higher
ratings of mania and lower values related to higher ratings of
depression [27].
In the present study we investigated correlations between VI, as
an objective measure of multi-scale characteristics of motility
rhythms, and self-assessed psychopathology including suicidal
thinking operationalized as a wish to die, in human subjects
monitored with actigraphic devices during an episode of major
depression. Our primary aim was to explore whether suicidal
thinking might correlate with this measure of psychomotor
activity. A secondary aim was to test the ability of VI to distinguish
between patients diagnosed clinically with bipolar versus unipolar
major depression.
Methods
Ethics Statement
All subjects provided written informed consent for aggregate
and anonymous reporting of data arising from their clinical and
actigraphic assessments. Study was approved by the Ethics
Committee of the University of Parma Medical Center, in full
accordance with international standards for the ethical use of
human subjects in research.
Clinical Procedures
Participants were recruited as outpatients at the Section of
Psychiatry of the University of Parma, Italy. Their DSM-IV
psychiatric diagnoses [7] were supported by semi-structured
interviews conducted repeatedly by research psychiatrists at intake
and at follow-up assessments over 7.4362.24 years.
Clinician ratings of subject symptom-severity were made at
study entry with the Young Mania Rating Scale (YMRS) and the
Hamilton Depression Rating Scale (HDRS) as reported previously
[26]. In addition, a total of 29 statements, (details are available on
request), describing subjective experiences of affective psychopa-
thology in layman’s language, were rated by study-participants as
0–10 on a 10 cm visual-analog scale anchored by ‘‘Not at all’’ and
‘‘Very much’’ [29], once-daily, at bedtime, on the three
consecutive days of actigraphic monitoring, and scores (1 cm-
increments) averaged across the three daily assessments were
statistically analyzed.
The 29 self-rated statements were devised and tested in
a decade-long study by a clinical-research consensus-workgroup
at the University of Parma seeking to capture potentially relevant
realms of subjective affective psychopathology, based on items of
the Bonn Scale for the Assessment of Basic Symptoms [30] and the
Hamburg Scale for mixed manic-depressive states and bipolar
illness [18,31]. Relevant areas identified by this process and
employed in the present study included vital drive or wish to live,
suicidal thinking or wish to die, depression, irritable mood
(dysphoria), anxiety, as well as unusual body-perception experi-
ences (cœnesthesias) and neurovegetative (autonomic nervous
system) symptoms.
In particular, the statement of primary interest here was
statement 15,’’Ho sentito il desiderio di morire o di essere morto’’
(‘‘I felt the wish to die or be dead’’ – translated by PS). The
remaining 28 statements measure 6 constructs: depression and
vital drive described in relation to psychomotor activity in
statements 2 & 3, to mood (statements 6 & 7), to train of thoughts
(statements 9 & 10), to verbal flow (statements 11 & 13), to hedonic
drive (statements 16 & 17), to libido (statements 18 & 19), and to
thought content (statements 28 & 29); dysphoria described in
relation to psychomotor activity in statements 1 and 5, to mood
(statement 4), to thought content (statement 8), and to verbal
behavior (statement 12); anxiety described in statement 14;
unusual body-perception experiences (coenesthesias) described in
Multi-Scale Motility and Suicidal Thinking
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statements 20–23, and neurovegetative (autonomic nervous
system) symptoms in statements 24–27.
The patient-subjects had a stable DSM-IV [7] diagnosis of
bipolar-I, bipolar-II, or unipolar major depressive disorder (n=12
subjects of each type). All subjects were in current episodes of
DSM-IV major depression with minimum symptom ratings of 26
(moderately severe) on the standard Hamilton Depression Rating
Scale (17-item HDRS), and #4 (minimal score) on the Young-
Mania Rating Scale (YMRS) [26]. No subject had a past or recent
history of suicidal attempts or deliberate self-harmful acts.
Actigraphy Data Analysis
Motility of each subject was recorded continuously for 72 hours
using an actigraphic device (AMI-128K Mini-MotionloggerH
Actigraph, Ambulatory Monitoring, Inc. [AMI], Ardsley, NY,
USA), worn on the non-dominant wrist continuously, 24 hours
a day under naturalistic, ambulatory conditions. The device
detected and recorded piezoelectric signals arising from body
movements, sampling at 32 Hz and integrating digitized data in 6-
minute epochs. The motility data contain rhythms at multiple
time-scales. As described previously [27], the amplitude of such
rhythms at various time-scales was obtained using a continuous
wavelet transform by convolution of the acquired data with
a scaled and translated version of a Morlet wavelet as a mother
wavelet. Wavelet transform is a powerful tool for estimating the
amplitudes from multi-scale data. Amplitude of the rhythms at
short time-scales appeared to be random; however its distribution
exhibited a long-tail characteristic with a scaling behavior at time-
scales up to 2 hours. Long-tail distribution is considered as
a signature of nonlinear complex systems near critical points, and
the Gamma function is used to characterize such distribution [28].
Hence we characterized the distribution of amplitudes at each
scale using a Gamma function fit. The shape parameter obtained
by the fit was integrated up to ,2 hours to derive VI.
Statistical Analysis
We compared subjects with DSM-IV-based diagnoses of type-I
or -II bipolar disorder or recurrent unipolar major depressive
disorder in a current episode of major depression. We based
statistical comparisons on ANOVA (F) methods for continuous
variables, and contingency tables (x2 or Fisher exact-p) for
categorical factors, with defined degrees-of-freedom (df). We used
multivariate logistic regression modeling to predict diagnostic
group from clinical and actigraphic factors. Based on multiple
linear regression modeling, we analyzed the relationship between
the objective measure VI and the subjective phenomenological
measures as well as clinical and diagnostic factors. Bayesian
characteristics were computed to distinguish bipolar depression
from unipolar depression. Averages are means with standard
deviations (6SD) unless stated otherwise. Analyses are based on
commercial statistical programs (Stata-9H, Stata Corp., College
Station, TX; Statview-5H, SAS Institute, Cary, NC).
Results
Characteristics of Patients with Major Depression
Representative motility data at selected time-scales obtained
from wavelet analysis along with the distribution of observed
amplitudes are shown in Figure 1. Although these subjects had
a disrupted activity profile due to irregular sleep/wake behavior,
the distribution of their motility amplitudes at multiple time-scales
exhibited a long-tail distribution.
Among the 36 subjects, diagnostic groups did not differ in
current age (F [df=2; 33] = 1.24, p=0.30), sex-distribution (x2
[df = 2] = 3.56, p=0.23), or baseline HDRS-scored depression-
severity (F [df = 2; 33] = 1.00, p=0.38; Table 1). However, mean
VI scores ranked: bipolar-II , bipolar-I , unipolar major
depressive disorders (Table 1). Multinomial logistic regression
modeling predicted diagnostic group from VI scores highly
significantly when unipolar major depressive disorder was the
reference group (x2 [df=2]= 24.3, p,0.001, Cox and Snell
pseudo-r2 = 0.49). Unipolar depressed patients differed from both
the bipolar-I (Wald statistic = 4.35, p=0.04) and bipolar-II cases
(Wald statistic = 10.9, p,0.001). When regression modeling
considered bipolar-I disorder patients as the reference group, VI
distinguished between bipolar disorder types I and II (Wald
statistic = 5.82, p=0.02).
Self-rated as well as clinician-rated severity of current de-
pression was similar across diagnoses, whereas ratings of suicidal
thoughts followed an opposite ranking to that for VI, with suicidal
ideation scores ranking: bipolar-II . bipolar-I . unipolar major
depressive disorders (Table 1). Clinician-based assessments found
the prevalence of dysphoria (irritable mood) during depression to
rank: bipolar-II . unipolar . bipolar-I diagnosis; bipolar-I
disorder subjects also scored significantly lower in self-rated vital
drive or wish to live than unipolar major depressive disorder
subjects (Table 1).
Relationship of VI and Self-assessed Phenomenological
Measures
Based on linear regression modeling of the relationship between
the objective measure VI and seven subjective phenomenological
measures, we found that: [i] the only factor strongly related to VI
(lower scores) was self-rated suicidal thinking, across diagnoses
(slope [b] factor = –0.233, t=–0.45, p,0.0001, based on
Pearson’s correlation, r=–0.61 [Figure 2]); [ii] no other factor
was associated with VI scores, including subjective self-assessments
of current depression, vital drive or wish to live, dysphoria,
anxiety, unusual body-perception experiences (cœnesthesias),
neurovegetative (autonomic nervous system) symptoms, and total
psychopathology (for the last of which b=–0.0006, t=–0.14,
p=0.89, r=–0.025); [iii] the association of lower VI with higher
suicidal self-ratings remained significant when modeling included
other factors (sex, diagnosis, clinician-rated dysphoria, self-rated
depression, and self-ratings of vital drive, dysphoria, anxiety,
unusual body-perception experiences [cœnesthesias], and auto-
nomic-neurovegetative symptoms); [iv] a multiple linear regression
model indicated that a strong association of VI score with lower
self-ratings of suicidal ideation but not with self-reported depressed
mood, remained even with other key factors added, and that VI
score was more associated with unipolar than bipolar (I or II)
diagnosis (Table 2). Vital drive itself also was independently
associated with VI scores [b= +0.022, t=2.27, p=0.03,
r=+0.292]).
A post-hoc statistical power analysis of multiple linear regression
accounting for number of predictors N=10, observed R2=0.37,
probability level a=0.05 and sample size n=36 found an observed
statistical power of p=0.77 that is close to the standard for
adequacy of power of p=0.80 conventionally established to avoid
probability of type II error or false negative rate, b=0.20.
We also computed Bayesian characteristics for detecting
bipolar depression and distinguishing it from unipolar de-
pression, based on a criterion value for elevated VI at $3.0.
This test-criterion yielded substantial and encouraging proba-
bilities for sensitivity (probability of detecting unipolar depression
[‘‘true-positive’’ test result]) of 91.7%, specificity (probability of
excluding bipolar depression) of 79.2%, and positive predictive value
(probability of identifying unipolar depression among all cases
Multi-Scale Motility and Suicidal Thinking
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with elevated VI) of 68.8%. We also considered VI scores and
self-rated suicidal thinking in bipolar disorder patients since
most (n = 10/12) unipolar depressed subjects reported a lack of
suicidal thoughts, in accord with the lower suicidal risk among
moderately depressed outpatients with unipolar disorder [32].
We found a strong correlation between VI scores and self-rated
suicidal thinking in the bipolar depressed patients (Figure 3).
Discussion
The strong negative association between VI and self-rated
suicidal thinking or wish to die, and its positive association with self-
Figure 1. Characterization of multi-scale amplitude of motility data by wavelet analysis from a representative subject with major
depression. (a) Raw data in arbitrary units (a.u), with amplitudes of rhythms detected at three time-scales. Subject shows a disrupted activity profile
due to disturbed sleep/wake cycle which is common in depressed subjects. (b) Rescaled probability distribution of amplitude obtained by rescaling
using Pmax to provide unit area of amplitude at a range of time-scales up to 2 hours. (c) The same data, log-transformed and showing a long-tail,
which share most of the values of log (APmax). (d) Gamma-distribution function fit of the amplitude distribution at a scale of 0.58 hours. The
goodness-of-fit is determined by Akaike information criteria in comparison with other distributions (20). (e) The shape parameter obtained from the
Gamma-function fit decreases at short time-scales and increases at long time-scales. VI is obtained by finding the area under the curve.
doi:10.1371/journal.pone.0038761.g001
Table 1. Characteristics of patients with major depression by DSM-IV diagnostic types.
Characteristics All Cases Bipolar-I Bipolar-II Unipolar x2 or F p-value
Cases (n) 36 12 12 12 – –
Women (%) 75.0 75.0 58.3 91.7 3.55 0.23
Age (years) 46.1612.7 41.7610.3 49.6614.6 47.0612.4 1.24 0.30
HDRS depression rating 30.462.21 30.562.28 30.961.88 29.762.42 1.00 0.379
Vulnerability index (VI) score 2.8460.94 2.8560.76 2.0460.60 3.6360.70 16.0 ,0.0001
Self-ratings
Vital drive (wish to live) 12.0612.4 4.9468.92 12.2612.4 18.7612.3 4.46 0.02
Suicidal thoughts (wish to die) 2.2062.44 1.7661.95 3.5362.42 1.2862.50 3.18 0.05
Depression 25.5615.6 24.0617.7 31.6616.3 20.8611.6 1.54 0.23
Unusual bodily sensations 4.7667.74 5.70611.3 3.8064.40 4.8466.50 0.16 0.85
Anxiety 2.5563.38 1.7262.56 3.0363.36 2.9064.17 0.54 0.59
Dysphoria 6.8065.90 6.0168.20 7.9864.51 6.3164.52 0.38 0.69
Autonomic symptoms 6.4466.52 3.3864.50 8.8666.86 7.1067.13 2.39 0.85
Total morbidity score 60.3639.8 47.6638.7 72.3640.8 61.9639.6 1.08 0.35
Clinician-rated dysphoria (%) 63.9 41.7 100.0 50.0 10.4 0.005
Statistical tests for diagnostic differences: for continuous variables, one-way ANOVA [df=2; 33] (F); for categorical values, contingency tables [df=2] (x2). Bonferroni-
adjusted criterion p,0.004 (0.05/13). Data are means 6SD unless stated otherwise. HRSD: Hamilton Rating Scale for Depression.
doi:10.1371/journal.pone.0038761.t001
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rated vital drive or wish to live suggest that VI may be associated
specifically with contrasting forces that often confront one other in
mood disorder patients–the wish to die and the wish to live [33].
The lack of correlations between VI and other subjective
phenomenological measures, including depressed mood, dyspho-
ria, anxiety, unusual body-perception experiences (cœnesthesias),
and autonomic-neurovegetative symptoms suggests at least two
levels of subjective psychopathology in depression: [a] experiences
of decreased fundamental vitality rooted in psychomotor activity
(reflected in VI scores), and [b] more cognitive experiences of
hopelessness-helplessness (self-rated depression) or of anguish, fear,
anger and distress (self-rated anxiety and dysphoria) associated with
abnormal somatic experiences (self-rated autonomic-cœnesthetic
symptoms). A similar perspective on descriptive mapping of human
emotional life into levels of particular feeling-states and emotions
was articulated nearly a century ago by Max Scheler [34]. Such an
approach, with a focus on specific elements of emotional life, might
provide a useful theoretical framework for future research,
including psychobiological studies, in mood disorders [35].
In spite of comparable levels of clinician-rated depression across
diagnoses, there were relevant differences in depressive phenom-
enology in bipolar disorders versus unipolar major depressive
disorder subjects. In particular, the higher scores for self-rated
suicidal ideation found in bipolar-II disorder subjects accord with
recent reports of high risks of suicide and attempts in both bipolar
I and II disorder patients, especially in relation with intense
impulsivity and dysphoria [32]. The greater prevalence of
clinician-rated dysphoria in the bipolar-II subjects versus those
with either bipolar-I or unipolar major depressive disorder also
accords with the same view of type-II bipolar disorder as an illness
underlined by impulsive-emotional dysregulation and possible
relations with other clinical syndromes characterized by impulsive-
emotional dyscontrol [36].
In addition, bipolar-I disorder subjects scored significantly lower
in self-rated vital drive or wish to live than unipolar major
depressive disorder subjects. This observation of a diminished self-
perceived level of vigor and vital drive, along with decreased
motility, confirms the greater likelihood in bipolar depression of
psychomotor retardation, lethargy, and lack of vitality compared
to unipolar depression [19,37,38]. Such phenomenological differ-
ences between unipolar and bipolar depressive episodes may be
related to neurobiological mechanisms including those underlying
attentional control, visuospatial and sensory processing, and
emotional regulation [39,40,41], differences in central mono-
aminergic systems [42,43], and altered electroencephalographic
patterns during sleep phases [44].
In light of the findings reported, we also hypothesize that
theoretical models for suicide research and prevention might profit
by shifting focus from monitoring of experiences of disturbed affect
and emotions to consideration of fundamental aspects of vitality
and psychomotor activity. Relevant considerations might include
two crucial clinical phenomena, potentially emerging during
major depression and long recognized in classical psychopathology
as associated with increased vulnerability to suicide. The first
phenomenon is a time during the process of recovery from
depression when psychomotor inhibition resolves before depressed
mood. This view predicts that suicidal impulses are more likely to
be acted upon at the particularly dangerous time of partial
recovery [45]. The second phenomenon involves the presence of
mixed affective states during bipolar depressive phases that can
create a highly explosive mixture of deep sadness, rage and despair
as well as psychomotor arousal associated with impulsive
aggression leading to self-harm or death [18].
Recent research on the neurobiology of suicidal behaviors
indicates that impulsive aggression as well as impaired judgment or
deficient risk assessment may constitute core endophenotypes of
Figure 2. Relationship of VI to self-rated suicidal ideation in
subjects with major depression. The negative correlation between
VI and self-rated suicidal ideation (r= –0.61) is highly significant
(p,0.0001) among depressed subjects (n= 36 bipolar I and II and
unipolar major depressive disorder subjects).
doi:10.1371/journal.pone.0038761.g002
Table 2. Multiple linear regression model of factors
associated with higher vulnerability index (VI) scores.
Factors Slope (b) [95%CI] t-score p-value
Unipolar . bipolar depression 0.946 [+0.469 to+1.42] 4.04 ,0.0001
Less self-reported suicidal
ideation
–0.199 [–0.302 to –0.096] 3.94 ,0.0001
Self-rated depression +0.005 [+0.011 to+0.021] 0.66 0.512
VI score was associated more strongly with unipolar than bipolar (I or II)
depression and with lower self-ratings of suicidal ideation or wish to die, but
was not associated with self-reported depressed mood. Factors not associated
with VI score included sex, age, clinician-rated dysphoria, and self-ratings of
dysphoria, vital drive, anxiety, unusual bodily experiences, autonomic
symptoms, or total morbidity.
doi:10.1371/journal.pone.0038761.t002
Figure 3. Relationship of VI to self-rated suicidal ideation in
bipolar-illness subjects with major depression. The negative
correlation between VI and self-rated suicidal ideation (r=–0.73) is
highly significant (p,0.0001) among bipolar depressed subjects (n= 24
bipolar I and II disorder subjects).
doi:10.1371/journal.pone.0038761.g003
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suicidality [11,13,17]. In addition, an aggressive diathesis can be
viewed as an imbalance between the diminished effects of
descending control systems in the orbital frontal and anterior
cingulate cortices, and excessive emotional and aggressive drives
arising from limbic elements including the amygdala and insula
[46]. The modulation or suppression mechanisms of aggressive
behavior with negative consequences provided by descending
control systems in the prefrontal cortex are both influenced by
predicting expectations of reward and punishment as well as by
early sensory and social information processing, and early
cognitive appraisal [46].
In light of this theoretical model of suicidal process we might
hypothesize that a sudden increase of subjectively perceived wish
to die might serve more as a provoking trigger stimulus of self-
aggression. However, a chronic and sustained self-perceived lack
of vigor and vitality might rather interfere with the mechanism of
aggressive diathesis as an influencing factor in early processing of
other provoking trigger stimuli.
The suggested association of VI with an inner balance between
subjective experiences of a wish to live versus a wish to die might
represent a complementary factor to be assessed and monitored
clinically alongside various other components and risk factors for
vulnerability to suicidal behavior. The need for better prediction of
suicidal risk is particularly important for evaluating persons with
a bipolar disorder, with predominantly dysphoric longitudinal
morbidity and with impulsive aggressive personality traits, as well
as those with psychotic mood disorders which also involve
impaired risk-assessment and enhanced proneness to violent
behavior.
Bipolar mood disorders are often characterized by particularly
severe, unstable, and frequently changing, long-term morbidity
leading to functional impairment and increased mortality.
Therefore, rational and safe clinical management of depressed
patients requires timely differentiation of bipolar and unipolar
mood disorders. In particular, it is challenging to differentiate
bipolar from unipolar disorders when early episodes present as
major depression and a history of mania or hypomania is not
available or not recognized, as is particularly likely in bipolar-II
disorder patients. We suggest that biological measures such as VI
might help to limit misdiagnosis and delayed or inappropriate
treatments.
Limitations of this study include sample size that was small but
sufficient to demonstrate a relationship of VI to suicidal ideation
and to diagnosis (Table 2). Although it is acknowledged that a small
sample size increases the risk of type II error and a power analysis
was not conducted prior to this proof of concept study, a post-hoc
analysis found statistical power to be adequate. In addition,
actigraphy monitoring needs to be repeated through various
morbid states and in subjects with versus without previous suicide
attempts. However, our previous research has shown that VI has
both stable (trait-like) and varying (state-like) features [27]. It is
possible that the association with suicidal thinking found here has
a trait component, and indeed there is external evidence that
suicidal behavior has this trait/state nature [47]. .
Additional studies are warranted to assess the stability of the
observed association of VI levels and suicidal ideation and to
extend it to suicidal behaviors and related measures (including
intent, plans and actions) through changing clinical states in-
cluding euthymia as well as in chronically suicide-contemplating
clients for suicide risk may lie well beyond observable mood
psychopathology. Long-term actigraphic monitoring of psycho-
motor disturbances might be also included in psychopharmaco-
logical studies of clinical depression as an objective correlate of
treatment response, as well as a measure to assist the clinical
appraisal of emerging suicidal risk when psychomotor arousal
precedes mood improvement [45].
In conclusion, the present findings indicate that VI, an objective
measure derived from analysis of motility rhythms recorded by
noninvasive, electronic actigraphy in depressed human subjects,
correlated inversely with suicidal ideation or a wish to die, and
elevated VI scores ($3.0) distinguished unipolar from bipolar
depression with favorable Bayesian characteristics. An objective
biomarker of suicidal ideation could be particularly advantageous
when patients are unwilling or unable to share suicidal thoughts
with clinicians. A patient’s determined suicidal intent, difficulties in
self-expression or an unsatisfactory therapeutic relationship are
circumstances that would benefit from an objective estimate of
suicidal thinking.
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